Understanding the Market | SISRAM MED rose over 6% after signing a commercial distribution cooperation agreement with Fosun Pharma (Jiangsu)
SISRAM MED rose over 6%, as of the time of writing, up 6.41%, priced at HKD 5.98, with a transaction volume of HKD 10.9752 million. In terms of news, SISRAM MED announced that SISRAM (Tianjin) and Fosun Pharma (Jiangsu) have signed a commercial distribution cooperation agreement. The group is responsible for providing commercial, marketing, medical education, and business planning services for the product injectable type A botulinum toxin, with the mainland trademark being Daxifei, in the region. The annual transaction cap for this agreement is USD 17 million, effective from yesterday until the end of this year and into the next year. The group indicated that this product is a re-licensed product by Fosun Pharma, used for the temporary improvement of moderate to severe frown lines caused by the activity of the corrugator and/or depressor supercilii muscles in adults. The group stated that the signing of the commercial distribution cooperation agreement will generate additional revenue
According to Zhitong Finance APP, SISRAM MED (01696) rose over 6%, as of the time of writing, up 6.41%, priced at HKD 5.98, with a transaction volume of HKD 10.9752 million.
In terms of news, SISRAM MED announced that SISRAM (Tianjin) and Fosun Wanbang (Jiangsu) have signed a commercial distribution cooperation agreement. The group is responsible for providing commercial, marketing, medical education, and business planning services for the product injectable type A botulinum toxin, with the mainland trademark being Daxifei, in the region. The annual transaction cap for this agreement is USD 17 million for both this year and next year. The group indicated that this product is a re-licensed product by Fosun Industry, used for the temporary improvement of moderate to severe frown lines caused by the activity of the corrugator and/or depressor supercilii muscles in adults. The group stated that the signing of the commercial distribution cooperation agreement will generate additional revenue
